Rajasthan, India

Kundan Singh Shekhawat

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kundan Singh Shekhawat: Innovator in Pharmaceutical Processes

Introduction

Kundan Singh Shekhawat is a notable inventor based in Rajasthan, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing quinoline-3-carboxamide derivatives. With a total of 3 patents to his name, Shekhawat's work has the potential to impact the pharmaceutical industry positively.

Latest Patents

One of his latest patents is titled "Process for preparing quinoline-3-carboxamide derivatives." This patent discloses an improved, commercially viable, and industrially advantageous process for the preparation of quinoline-3-carboxamide derivatives, such as laquinimod, or a pharmaceutically acceptable salt thereof, in high yield and purity. This innovative process showcases his commitment to enhancing pharmaceutical manufacturing techniques.

Career Highlights

Throughout his career, Kundan Singh Shekhawat has worked with prominent companies, including Actavis Group Ptc Ehf. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical processes.

Collaborations

Some of his notable coworkers include Girish Dixit and Krishnadatt Sharma. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of impactful pharmaceutical solutions.

Conclusion

Kundan Singh Shekhawat's contributions to the field of pharmaceuticals through his innovative processes and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in drug development and manufacturing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…